Will Tirzepatide Slow Kidney Function Decline in Type 2 Diabetes? - Medscape

6/3/2022 12:00:00 AM2 years 11 months ago
by Marlene Busko
by Marlene Busko
Compared with insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with type 2 diabetes at high cardiovascular risk but mainly normal kidney function.
Dr Hiddo J.L. Heerspink The twincretin tirzepatide might become part of the arsenal against diabetic kidney disease, new research suggests. Notably, the drug significantly reduced the likelihood of … [+6723 chars]
full article...